new targets [10] [11] [12] . Xu et al. now describe how the virus manipulates the biogenesis of these structures 2 . Among HIV-1 proteins, Nef is necessary and sufficient for enhancing the formation of these actin-propelled intercellular conduits by a mechanism mediated by the adaptor Vav and dependent on GTPases that involves the myristoylated anchor, central core and flexible loop domains of the viral protein 2 . Thus, in this scenario ( Fig. 1) , Nef acts both in the infected macrophage, to induce the conduits that will contact other cells, and then in B cells, where it impairs cellular functions.
What is the relevance of these observations? The authors show that in lymphoid tissues, HIV-infected macrophages are in close proximity to B cells. Furthermore, Nef can be detected in intercellular conduits linking macrophages and B cells, as well as in B cells. Immunohistology of germinal centers shows that there is lower expression of activationinduced cytidine deaminase and other proteins involved in CD40 ligand-mediated signaling pathways, as well as less abundant IgG2 and IgA, consistent with the inhibition of immunoglobulin class switching in B cell cultures exposed to Nef 3 . Finally, the authors compare samples from long-term nonprogressors (patients infected with HIV whose infection does not progress to AIDS) infected with Nefdeficient or wild-type HIV-1. Despite having somewhat similar virological and immunological parameters, including low viral loads, normal CD4 + T cell counts and normal total serum titers of IgM, IgG and IgA, people infected with Nef-deficient HIV-1 have more IgG2, IgA1 and IgA2 specific for viral proteins than do long-term nonprogressors infected with wild-type HIV 2 . These results are consistent with involvement of Nef, either direct or indirect, in the alteration of immunoglobulin class switching.
These findings raise various intriguing questions. The tunneling nanotube-like structures formed by HIV-1-infected cells have been shown before to contain Gag and Env proteins and to transfer viruses to target T cells [9] [10] [11] [12] I mmunological self-tolerance requires the continuous vigilance of overlapping but nonredundant mechanisms to prevent the escape and activation of pathogenic autoreactive lymphocytes. Known mechanisms include, but are not limited to, the generation of regulatory T cells, the requirement for a second signal for activation of naive T cells, skewing of T cell subsets by the cytokine milieu, immunological sequestration of certain organs and negative selection of autoreactive thymocytes. That such a diverse array of mechanisms must all work in concert to prevent autoimmunity highlights the complexity of the problem of self versus nonself discrimination and the delicate balance that exists between robust pathogen elimination and self-reactivity. It is widely accepted that promiscuous expression of genes encoding tissue-specific antigens (TSAs) in thymic stroma is essential for immune tolerance, but evidence suggests that TSA-expressing stroma in the secondary lymphoid organs may serve as an additional checkpoint to eliminate or shut down self antigen-specific T cells that escape negative selection in the thymus. The immunological relevance of this phenomenon remains unclear, but a study by Yip et al. in this issue of Nature Immunology provides further support for the idea that secondary lymphoid organs are sites of promiscuous expression of genes encoding TSAs and that fluctuations in TSA expression in the pancreatic lymph nodes (PLNs) correlate with progression toward autoimmune type 1 diabetes in nonobese diabetic (NOD) mice 1 . In addition, Yip et al. identify the SAND domaincontaining transcriptional regulator deformed epidermal autoregulatory factor 1 (Deaf1) as a potential mediator of this process.
When pancreas-specific promoters were first used to drive expression of SV40 T antigen in transgenic mice, a number of groups reported transgene expression in the thymus in addition to the expected expression in the target tissue; this thymic expression resulted in antigenspecific T cell tolerance 2, 3 . It soon became clear that thymic medullary epithelial cells have low expression of endogenous antigens representing a wide range of tissues 4 . The subsequent discovery that much of this promiscuous thymic gene expression depends on the transcriptional regulator Aire and that mice and humans lacking functional Aire develop devastating autoimmunity 5, 6 lent credence to the idea that a faithful thymic representation of the peripheral self is essential for normal immune homeostasis.
More recent evidence indicates that something similar may occur in the secondary lymphoid organs. Experiments using the promoter of the gene encoding intestinal fatty acidbinding protein to drive ovalbumin expression have shown that the lymphoid stroma promiscuously expresses ovalbumin as well as a host of other tissue-specific transcripts, which in turn leads to the deletion of adoptively transferred ovalbumin-specific CD8 + T cells 7 . Similarly, the endogenous melanocyte antigen tyrosinase is expressed by lymphoid stroma and causes the deletion of cognate CD8 + T cells that are not negatively selected in the thymus 8 . Subsequent work has described a population of extrathymic Aire-expressing cells in the peripheral lymphoid stroma that express a host of Aire-regulated TSAs distinct from those regulated by Aire in the thymus and whose interaction with naive cognate CD8 + T cells leads to deletion 9 .
The report by Yip et al. supports the idea that TSA expression occurs in the secondary lymphoid organs and identifies a putative regulator of such TSA expression, Deaf1. On the basis of their previous studies 10 , the authors use microarrays to monitor changes in gene expression in whole PLNs of NOD mice before, during and after disease onset. Comparison of these transcriptional profiles with those of the congenic but nondiabetic NOD.B10 strain reveals that the PLNs of NOD mice express a range of TSA transcripts, including those encoding insulin, pancreatic polypeptide and regenerating isletderived IIIγ; expression of these transcripts in diabetic mice fluctuates coordinately in concert with disease progression and is generally low during the approximate window of disease onset. As Deaf1 expression in the PLNs fluctuates in parallel with TSA expression and Deaf1 bears some general structural similarity to Aire, Yip et al. choose to further investigate the role of Deaf1 in peripheral TSA expression.
Deaf1 itself is a DNA-binding protein first identified in drosophila as a regulator of the homeotic gene Deformed 11 , which facilitates anterior segment development. Loss-of-function mutations in drosophila Deaf1 lead to segmentation defects and death during embryonic development, whereas Deaf1 overexpression leads to altered wing and eye formation 12 . The mouse ortholog Deaf1 is expressed in a wide variety of fetal and adult tissues 13 , and mice lacking functional Deaf1 exhibit a range of anterior-bodyplan defects, including exencephaly, failure of neural tube closure and skeletal abnormalities in the rib cage and cervical vertebrae 14 . Deaf1 is also widely expressed in the adult mouse and regulates, for example, the proliferation and branching of mammary epithelium 15 .
To more directly test the role of Deaf1 in TSA expression, Yip et al. analyze by microarray whole PLNs from wild-type and Deaf1-deficient mice. This analysis indicates that Deaf1 positively and negatively regulates the expression of a host of genes, including a substantial number encoding TSAs in the PLNs. Strikingly, 22 of the 30 most highly Deaf1-induced genes are tissue specific, and the set of Deaf1-regulated TSAs identified by microarray shares some overlap with Aire-regulated genes in the thymus, although Aire transcription itself is unchanged in Deaf1-deficient lymph nodes. Conversely, the set of Deaf1-regulated genes in the PLNs is almost entirely distinct from the set of genes regulated by Aire in the secondary lymphoid organs 9 , which suggests that these systems may be independent or complementary. Similarly, knockdown of Deaf1 in vitro causes lower expression of candidate TSAs. Finally, although no organ-specific autoimmune infiltration or tissue destruction is observed in mice lacking Deaf1, modest nonspecific antibody reactivity to retinal tissues is detected. The absence of overt autoimmunity in these mice may be partly due to the BALB/c genetic background but suggests that whatever defects in self-tolerance exist in the absence of Deaf1 may be subtle.
On closer examination, Yip et al. also detect a previously unknown Deaf1 splice variant. The PLNs of prediabetic NOD mice are enriched for this variant, which contains an intronic insertion that introduces a premature stop codon leading to loss of the nuclear-localization signal as well as other carboxy-terminal domains of the protein. Unlike canonical Deaf1, the splice variant is sequestered mainly in the cytoplasm in vitro and can bind to canonical Deaf1, potentially interfering with its ability to induce transcription. The authors identify a similar splice variant deficient in the nuclearlocalization signal in the PLNs of humans and, intriguingly, the PLNs of patients with type 1 diabetes show substantial enrichment for this variant. The authors hypothesize that this splice variant may interfere with the normal function of Deaf1, leading to reduced expression of Deaf1-dependent TSA genes in the PLN at critical points during the progression of type 1 diabetes.
Taken together, these results raise the interesting possibility that TSA expression in the PLNs may facilitate protection from type 1 diabetes and that Deaf1 may serve an important role in this process. However, a number of important questions and considerations remain. The identity of the Deaf1-expressing cells involved in this process and their relationship to previously characterized stromal populations, including lymph node stromal cells positive for the agglutinin UEA-1 and the cell surface glycoprotein gp38 (ref. 7) and extrathymic Aire-expressing cells 9 , will be of considerable interest (Fig. 1) . The present study, for the most part, examines TSA expression in whole lymph nodes, although Yip et al. do document expression of Deaf1 and candidate TSAs in CD45 -lymph node stromal elements. However, Deaf1, unlike Aire, is expressed in a wide array of tissues, and the precise relationship between Deaf1-expressing lymph node stromal elements and previously described populations in the lymphoid organs remains to be defined. It will also be informative to determine whether Deaf1 regulates TSA expression directly. Unlike Aire, Deaf1 has direct DNA- binding ability in its SAND domain, and discrete Deaf1 response elements have been identified 16 . It will be interesting, therefore, to determine whether Deaf1-regulated genes encoding TSAs contain such response elements and whether direct interaction between Deaf1 and promoter regions in genes encoding TSAs can be detected. Furthermore, it is important to note that despite the potential promise of TSA expression in secondary lymphoid organs, the extent and biological relevance of this phenomenon remains largely speculative. To our knowledge no study has yet shown directly that promiscuous TSA expression in the secondary lymphoid stroma is either necessary or sufficient to prevent autoimmunity. Although the present study identifies a mild predisposition toward autoantibody reactivity among Deaf1-deficient mice, it is not yet clear whether this defect 'maps' to secondary lymphoid organs and a defect in TSA expression or whether it reflects part of the larger developmental disruption seen in the setting of systemic Deaf1 deficiency. Indeed, although the decrease in TSA and Deaf1 expression in the PLNs of NOD mice at 12 weeks provides evidence of a correlation between promiscuous gene expression and autoimmunity, the causal relationship between the two is less clear. To this end, it will also be important to directly demonstrate that Deaf1-dependent alterations in TSA expression have functional consequences for peripheral T cell selection and/or function. Ultimately, it must be determined whether and why such TSA expression in the secondary lymphoid organs is necessary given its clear role in the thymus and the efficiency of thymic negative selection. One answer may lie in the complementary rather than redundant nature of central and peripheral TSA expression. volume 10 number 9 september 2009 nature immunology 
Maintaining immune homeostasis in fly gut

François Leulier & Julien Royet
Like every metazoan species hosting a gut flora, drosophila tolerate commensal microbiota yet remain able to mount an efficient immune response to food-borne pathogens. New findings explain how the quantity of reactive oxygen species in the gut is 'tuned' to microbial burden and how intestinal immune homeostasis is thereby maintained.
V
ertebrates and invertebrates live in a complex microbial world and inhale and ingest microorganisms, a small fraction of which reach and colonize epithelial surfaces. Therefore, microbes not only exist all around but also live within organisms, mainly in the digestive tract, where they can establish a symbiotic relationship with the host. Studies of gnotobiotic and germ-free mice have indicated an important function for resident bacteria in supplying essential nutrients, metabolizing indigestible compounds, defending against colonization by opportunistic pathogens and even contributing to the development of the intestinal tissues 1 . Thus, the gut epithelium apparently tolerates the proliferation of commensal bacteria to a certain extent to allow beneficial interactions to take place. How does the gut epithelium tolerate commensal bacteria while retaining the ability to trigger an efficient immune response after infection with pathogenic bacteria? In an elegant study in this issue of Nature Immunology, Ha et al. 2 use Drosophila melanogaster as a model system to identify and delineate the signaling networks that control the abundance of antimicrobial reactive oxygen species (ROS) in the gut. They demonstrate that finely tuned regulation of this signaling network allows commensal microbiota to persist in the gut and prevents the proliferation of dangerous pathogens.
Over the past 15 years, drosophila has been a very useful model for 'deciphering' innate immune defense mechanisms that are conserved in the animal kingdom 3 . Like most multicellular organisms, drosophila contain commensal bacteria in their gut and have developed sophisticated mechanisms to tolerate them. However, the drosophila gut flora is much simpler that the mammalian one. Whereas the human gut is thought to host between 500 and 1,000 bacterial phylotypes, this number is more likely around 10-20 for drosophila 4 . Taking advantage of this relative simplicity, various studies have begun to unravel the mechanisms underlying the innate immune homeostasis of the drosophila intestinal tract.
The drosophila gut immune response relies mainly on two types of molecular effectors that act synergistically to restrict the growth and proliferation of invading microorganisms: the antimicrobial peptides (AMPs) and ROS. Production of these mediators is tightly regulated to prevent the proliferation of foodborne pathogens but preserve the commensal microbiota. The molecular basis of the transcriptional regulation of genes encoding AMPs is quite well understood (Fig. 1) . Whereas the transcription of genes encoding AMPs is under the control of both the Toll and immune deficiency (IMD) signaling pathways in the fat body systemic antimicrobial response, it is
